Subchondral bone as a key target for osteoarthritis treatment

Biochemical Pharmacology

Volumn 83, Issue 3, 2012, Pages 315-323

  Castañeda, Santos ^a   Roman Blas, Jorge A ^a   Largo, Raquel ^a   Herrero Beaumont, Gabriel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Antiresorptives; New therapies; Osteoarthritis; Pathogenesis; Subchondral bone

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; AMINO TERMINAL TELOPEPTIDE; BALICATIB; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CENTCHROMAN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PYRIDINOLINE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; TAMOXIFEN; TIBOLONE;

ANGIOGENESIS; ARTHRALGIA; BONE PLATE; BONE TURNOVER; CLINICAL TRIAL (TOPIC); DISEASE COURSE; HORMONE SUBSTITUTION; HUMAN; JOINT FUNCTION; JOINT STIFFNESS; MICROFRACTURE; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; REVIEW; VISCOELASTICITY;

EID: 84455202518     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.018     Document Type: Note

References (99)

1. J. Sellam, G. Herrero-Beaumont, and F. Berenbaum Osteoarthritis: pathogenesis, clinical aspects and diagnosis J.W.J. Bijlsma, G.R. Burmester, J.A. P de Silva, K.L. Faarvang, E. Hachulla, X. Mariette, EULAR compendium on rheumatic diseases 2009 BMJ Publishing Group Ltd. Italy 444 463
2. G. Herrero-Beaumont, J.A. Roman-Blas, S. Castañeda, and S. Jiménez Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics Semin Arthritis Rheum 39 2009 71 80
3. M.B. Goldring, and S.R. Goldring Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis Ann N Y Acad Sci 1192 2010 230 237
4. S.R. Goldring Role of bone in osteoarthritis pathogenesis Med Clin North Am 93 2009 25 35
5. D. Lajeunesse, and P. Reboul Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling Curr Opin Rheumatol 15 2003 628 633 (Pubitemid 37041404)
6. P.C. Pastoureau, A.C. Chomel, and J. Bonnet Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis Osteoarthritis Cartilage 7 1999 466 473 (Pubitemid 29468741)
7. J.S. Day, M. Ding, J.C. van der Linden, I. Hvid, D.R. Sumner, and H. Weinans A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage J Orthop Res 19 2001 914 918 (Pubitemid 32799082)
8. T. Hayami, M. Pickarski, Y. Zhuo, G.A. Wesolowski, G.A. Rodan, and T. Duong le Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis Bone 38 2006 234 243 (Pubitemid 43165790)
9. G. Herrero-Beaumont, J.A. Roman-Blas, R. Largo, F. Berenbaum, and S. Castañeda Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis Ann Rheum Dis 70 2011 1523 1525
10. M.C. Nevitt, Y. Zhang, M.K. Javaid, T. Neogi, J.R. Curtis, and J. Niu High systemic bone mineral density increases the risk of incident knee OA and joint space narrowing, but not radiographic progression of existing knee OA: the MOST study Ann Rheum Dis 69 2010 163 168
11. E. Calvo, S. Castañeda, R. Largo, M.E. Fernández-Valle, F. Rodríguez-Salvanés, and G. Herrero-Beaumont Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits Osteoarthritis Cartilage 15 2007 69 77 (Pubitemid 46117909)
12. D. Burr Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis Osteoarthritis Cartilage Suppl. A 2004 S20 S30
13. H. Imhof, I. Sulzbacher, S. Grampp, C. Czerny, S. Youssefzadeh, and F. Kainberger Subchondral bone and cartilage disease: a rediscovered functional unit Invest Radiol 35 2000 581 588
14. R.J. Lories, and F.P. Luyten The bone-cartilage unit in osteoarthritis Nat Rev Rheumatol 7 2011 43 49
15. E.L. Radin, and R.M. Rose Role of subchondral bone in the initiation and progression of cartilage damage Clin Orthop Relat Res 213 1986 34 40 (Pubitemid 17187796)
16. C.S. Carlson, R.F. Loeser, C.B. Purser, J.F. Gardin, and C.P. Jerome Osteoarthritis in cynomolgus macaques. III: Effects of age, gender, and subchondral bone thickness on the severity of disease J Bone Miner Res 11 1996 1209 1217 (Pubitemid 26282520)
17. P. Pastoureau, S. Leduc, A. Chomel, and F. De Ceuninck Quantitative assessment of articular cartilage and subchondral bone histology in the meniscectomized guinea pig model of osteoarthritis Osteoarthritis Cartilage 11 2003 412 423 (Pubitemid 36722655)
18. A. Kadri, H.K. Ea, C. Bazille, D. Hannouche, F. Lioté, and M.E. Cohen-Solal Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis Arthritis Rheum 58 2008 2379 2386
19. P. Dieppe, J. Cushnaghan, P. Young, and J. Kirwan Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy Ann Rheum Dis 52 1993 557 563 (Pubitemid 23246656)
20. A.J. Bailey, C. Buckland-Wright, and D. Metz The role of bone in osteoarthritis Age Ageing 30 2001 374 378 (Pubitemid 33069590)
21. L.S. Lohmander, L.M. Atley, T.A. Pietka, and D.R. Eyre The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis Arthritis Rheum 48 2003 3130 3139 (Pubitemid 37409324)
22. P. Bettica, G. Cline, D.J. Hart, J. Meyer, and T.D. Spector Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study Arthritis Rheum 46 2002 3178 3184 (Pubitemid 35453526)
23. D.T. Felson, S. McLaughlin, J. Goggins, M.P. LaValley, M.E. Gale, and S. Totterman Bone marrow edema and its relation to progression of knee osteoarthritis Ann Intern Med 139 2003 330 336
24. K. Redlich, S. Hayer, R. Ricci, J.P. David, M. Tohidast-Akrad, and G. Kollias Osteoclasts are essential for TNF-alpha-mediated joint destruction J Clin Invest 110 2002 1419 1427 (Pubitemid 35396913)
25. M.B. Goldring, and K.B. Marcu Cartilage homeostasis in health and rheumatic diseases Arthritis Res Ther 11 2009 224
26. J. Moreno-Rubio, G. Herrero-Beaumont, L. Tardio, M.A. Alvarez-Soria, and R. Largo Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis Arthritis Rheum 62 2010 478 488
27. C.I. Westacott, G.R. Webb, M.G. Warnock, J.V. Sims, and C.J. Elson Alteration of cartilage metabolism by cells from osteoarthritic bone Arthritis Rheum 40 1997 1282 1291 (Pubitemid 27430140)
28. F. Massicotte, D. Lajeunesse, M. Benderdour, J.P. Pelletier, G. Hilal, and N. Duval Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients Osteoarthritis Cartilage 10 2002 491 500 (Pubitemid 34679302)
29. A. Pilichou, I. Papassotiriou, K. Michalakakou, S. Fessatou, E. Fandridis, and G. Papachristou High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis Clin Biochem 41 2008 746 749
30. S. Kwan Tat, N. Amiable, J.P. Pelletier, C. Boileau, D. Lajeunesse, and N. Duval Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis Rheumatology (Oxford) 48 2009 1482 1490
31. M. Bellido, L. Lugo, J.A. Roman-Blas, S. Castañeda, J.R. Caeiro, and S. Dapia Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis Arthritis Res Ther 12 2010 R152
32. H. Komuro, T. Olee, K. Kühn, J. Quach, D.C. Brinson, and A. Shikhman The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage Arthritis Rheum 44 2001 2768 2776 (Pubitemid 34016196)
33. I. Pantsulaia, L. Kalichman, and E. Kobyliansky Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers Osteoarthritis Cartilage 18 2010 1448 1453
34. J.P. Pelletier, E. Troncy, T. Bertaim, D. Thibaud, A.C. Goulet, and F. Abram Treatment with tiludronic acid helps reduce the development of experimental osteoarthritis lesions in dogs with anterior cruciate ligament transection followed by reconstructive surgery: a 1-year study with quantitative magnetic resonance imaging J Rheumatol 38 2011 118 128
35. K.D. Brandt, S.L. Myers, D. Burr, and M. Albrecht Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament Arthritis Rheum 34 1991 1560 1570
36. P. Sambrook, and V. Naganathan What is the relationship between osteoarthritis and osteoporosis? Baillieres Clin Rheumatol 11 1997 695 710 (Pubitemid 28005898)
37. J. Dequeker, J. Aerssens, and F.P. Luyten Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship Aging Clin Exp Res 15 2003 426 439 (Pubitemid 37509168)
38. M.C. Hochberg, M. Lethbridge-Cejku, and J.D. Tobin Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging Osteoarthritis Cartilage 12A 2004 S45 S48
39. J.A. Roman-Blas, S. Castañeda, R. Largo, and G. Herrero-Beaumont Osteoarthritis associated with estrogen deficiency Arthritis Res Ther 11 2009 R241
40. K.D. Brandt, P. Dieppe, and E.L. Radin Commentary: is it useful to subset "primary" osteoarthritis? A critique based on evidence regarding the etiopathogenesis of osteoarthritis Semin Arthritis Rheum 39 2009 81 95
41. B.W. Strassle, L. Mark, L. Leventhal, M.J. Piesla, X. Jian Li, and J.D. Kennedy Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease Osteoarthritis Cartilage 18 2010 1319 1328
42. K.D. Ham, R.F. Loeser, B.R. Lindgren, and C.S. Carlson Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys Arthritis Rheum 46 2002 1956 1964 (Pubitemid 34774529)
43. T.Y. Ho, K. Santora, J.C. Chen, A.L. Frankshun, and C.A. Bagnell Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis Bone 48 2011 1346 1353
44. A.S. Turner, K.A. Athanasiou, C.F. Zhu, M.R. Alvis, and H.U. Bryant Biochemical effects of estrogen on articular cartilage in ovariectomized sheep Osteoarthritis Cartilage 5 1997 63 69 (Pubitemid 27063752)
45. Y.H. Sniekers, H. Weinans, S.M. Bierma-Zeinstra, J.P. van Leeuwen, and G.J. van Osch Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach Osteoarthritis Cartilage 16 2008 533 541
46. M.Z. Yan, Y. Xu, Y.X. Gong, J.M. Liu, S.Y. Lu, and L. Huang Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism Endocrine 37 2010 55 61
47. S. Canpolat, N. Tug, A.D. Seyran, S. Kumru, and B. Yilmaz Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats J Physiol Biochem 66 2010 23 28
48. T. Hayami, M. Pickarski, G.A. Wesolowski, J. McLane, A. Bone, and J. Destefano The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model Arthritis Rheum 50 2004 1193 1206 (Pubitemid 38480830)
49. M.R. Doschak, G.R. Wohl, D.A. Hanley, R.C. Bray, and R.F. Zernicke Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee J Orthop Res 22 2004 942 948 (Pubitemid 39145108)
50. M.A. Karsdal, I. Byrjalsen, D.J. Leeming, and C. Christiansen Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation BMC Musculoskelet Disord 9 2008 153 160
51. A. Kadri, T. Funck-Brentano, H. Lin, H.K. Ea, D. Hannouche, and C. Marty Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling Ann Rheum Dis 69 2010 1533 1538
52. M. Moreau, P. Rialland, J.P. Pelletier, J. Martel-Pelletier, D. Lajeunesse, and C. Boileau Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model Arthritis Res Ther 13 2011 R98
53. T.D. Spector Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis Aging Clin Exp Res 15 2003 413 418 (Pubitemid 37509166)
54. A. Corrado, N. Santoro, and F.P. Cantatore Extra-skeletal effects of bisphosphonates Joint Bone Spine 74 2007 32 38 (Pubitemid 46240986)
55. K.G. Saag Bisphosphonates for osteoarthritis prevention: "Holy Grail" or not? Ann Rheum Dis 67 2008 1358 1359
56. P. Richette, M. Corvol, and T. Bardin Estrogens, cartilage and osteoarthritis Joint Bone Spine 70 2003 257 262
57. J.A. Gokhale, S.R. Frenkel, and P.E. Dicesare Estrogen and osteoarthritis Am J Orthop 33 2004 71 80
58. S. Castañeda, R. Largo, E. Calvo, M. Bellido, C. Gómez-Vaquero, and G. Herrero-Beaumont Effects of estrogen deficiency and low bone mineral density on healthy knee cartilage in rabbits J Orthop Res 28 2010 812 818
59. M.C. Nevitt, S.R. Cummings, N.E. Lane, M.C. Hochberg, J.C. Scott, and A.R. Pressman Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group Arch Intern Med 156 1996 2073 2080 (Pubitemid 26346965)
60. Y. Zhang, T.E. McAlindon, M.T. Hannan, C.E. Chaisson, R. Klein, and P.W.F. Wilson Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: The Framingham Study Arthritis Rheum 41 1998 1867 1873 (Pubitemid 28465542)
61. T.D. Spector, D. Nandra, D.J. Hart, and D.V. Doyle Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford study Ann Rheum Dis 56 1997 432 434 (Pubitemid 27345263)
62. P. Ravn, L. Warming, S. Christgau, and C. Christiansen The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy Bone 35 2004 1216 1221 (Pubitemid 39487369)
63. D.J. Cirillo, R.B. Wallace, L. Wu, and R.A. Yood Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative Arthritis Rheum 54 2006 3194 3204 (Pubitemid 44622090)
64. M.C. Nevitt, D.T. Felson, E.N. Williams, D. Grady Heart and Estrogen/Progestin Replacement Study Research Group The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: the Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial Arthritis Rheum 44 2001 811 818 (Pubitemid 32319773)
65. M.D. Jones, C.W. Tran, G. Li, W.P. Maksymowych, R.F. Zernicke, and M.R. Doschak In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat Arthritis Rheum 62 2010 2726 2735
66. C. Muehleman, J. Green, J.M. Williams, K.E. Kuettner, E.J. Thonar, and D.R. Sumner The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage Osteoarthritis Cartilage 10 2002 226 233 (Pubitemid 34189573)
67. M. Ding, C.C. Danielsen, and I. Hvid The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis Calcif Tissue Int 82 2008 77 86
68. T.D. Spector, P.G. Conaghan, J.C. Buckland-Wright, P. Garnero, G.A. Cline, and J.F. Beary Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial Arthritis Res Ther 7 2005 R625 R633
69. C.O. Bingham, J.C. Buckland-Wright, P. Garnero, S.B. Cohen, M. Dougados, and S. Adami Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study Arthritis Rheum 54 2006 3494 3507 (Pubitemid 44737161)
70. J.C. Buckland-Wright, E.A. Messent, C.O. Bingham 3rd, R.J. Ward, and C. Tonkin A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients Rheumatology (Oxford) 46 2007 257 264 (Pubitemid 46189786)
71. T. Neogi, M.C. Nevitt, K.E. Ensrud, D. Bauer, and D.T. Felson The effect of alendronate on progression of spinal osteophytes and disc-space narrowing Ann Rheum Dis 67 2008 1427 1430
72. L.D. Carbone, M.C. Nevitt, K. Wildy, K.D. Barrow, F. Harris, and D. Felson The relationship of antiresortive drug use to structural findings and symptoms of knee osteoarthritis Arthritis Rheum 50 2004 3516 3525 (Pubitemid 39488676)
73. P. Garnero, W.S. Aronstein, S.B. Cohen, P.G. Conaghan, G.A. Cline, and C. Christiansen Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial Osteoarthritis Cartilage 16 2008 660 666 (Pubitemid 351760798)
74. C. Behets, J.M. Williams, D. Chappard, J.P. Devogelaer, and D.H. Manicourt Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency J Bone Miner Res 19 2004 1821 1826 (Pubitemid 41103433)
75. N.A. Papaioannou, I.K. Triantafillopoulos, L. Khaldi, N. Krallis, A. Galanos, and G.P. Lyritis Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study Osteoarthritis Cartilage 15 2007 386 395 (Pubitemid 46381571)
76. R.H. Nielsen, A.C. Bay-Jensen, I. Byrjalsen, and M.A. Karsdal Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover Osteoarthritis Cartilage 19 2011 466 473
77. D.H. Manicourt, R.D. Altman, J.M. Williams, J.P. Devogelaer, A. Druetz-Van Egeren, and M.E. Lenz Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions Arthritis Rheum 42 1999 1159 1167 (Pubitemid 29268952)
78. H. El Hajjaji, J.M. Williams, J.P. Devogelaer, M.E. Lenz, E.J. Thonar, and D.H. Manicourt Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis Osteoarthritis Cartilage 12 2004 904 911 (Pubitemid 39462605)
79. C.H. Chesnut 3rd, M. Azria, S. Silverman, M. Engelhardt, M. Olson, and L. Mindeholm Salmon calcitonin: a review of current and future therapeutic indications Osteoporos Int 19 2008 479 491
80. M.A. Karsdal, I. Byrjalsen, K. Henriksen, B.J. Riis, E.M. Lau, and M. Arnold The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study Osteoarthritis Cartilage 18 2010 150 159
81. J.K. Chang, L.H. Chang, S.H. Hung, S.C. Wu, H.Y. Lee, and Y.S. Lin Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats Arthritis Rheum 60 2009 3049 3060
82. M. Bellido, L. Lugo, J.A. Roman-Blas, S. Castañeda, E. Calvo, and R. Largo Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis Osteoarthritis Cartilage 19 2011 1228 1236
83. O. Malaise, O. Bruyere, and J.Y. Reginster Strontium ranelate normalizes bone mineral density in osteopenic patients Aging Clin Exp Res 19 2007 330 333 (Pubitemid 47496895)
84. Y. Henrotin, A. Labasse, S.X. Zheng, P. Galais, Y. Tsouderos, and J.M. Crielaard Strontium ranelate increases cartilage matrix formation J Bone Miner Res 16 2001 299 308 (Pubitemid 32105411)
85. S.K. Tat, J.P. Pelletier, F. Mineau, J. Caron, and J. Martel-Pelletier Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts Bone 49 2011 559 567
86. O. Bruyere, D. Delferriere, C. Roux, J.D. Wark, T. Spector, and J.P. Devogelaer Effects of strontium ranelate on spinal osteoarthritis progression Ann Rheum Dis 67 2008 335 339 (Pubitemid 351281267)
87. P. Alexandersen, M.A. Karsdal, P. Qvist, J.Y. Reginster, and C. Christiansen Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women Bone 40 2007 218 222 (Pubitemid 44848419)
88. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, and R. Lüthy Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319 (Pubitemid 27199902)
89. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, and T. Burgess Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176 (Pubitemid 28180851)
90. M.M. Hardy, K. Seibert, P.T. Manning, M.G. Currie, B.M. Woerner, and D. Edwards Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants Arthritis Rheum 46 2002 1789 1803 (Pubitemid 34774511)
91. R. Largo, I. Díez-Ortego, O. Sanchez-Pernaute, M.J. López-Armada, M.A. Alvarez-Soria, and J. Egido EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts Ann Rheum Dis 63 2004 1197 1204 (Pubitemid 39273493)
92. X. Li, M. Ellman, P. Muddasani, J.H. Wang, G. Cs-Szabo, and A.J. van Wijnen Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis Arthritis Rheum 60 2009 513 523
93. L. Zeng, S. An, and E.J. Goetzl EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells J Pharmacol Exp Ther 286 1998 1420 1426 (Pubitemid 29135557)
94. P. Clark, S.E. Rowland, D. Denis, M.C. Mathieu, R. Stocco, and H. Poirier MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3- methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis J Pharmacol Exp Ther 325 2008 425 434 (Pubitemid 351574801)
95. A. Murase, T. Okumura, A. Sakakibara, H. Tonai-Kachi, K. Nakao, and J. Takada Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation Eur J Pharmacol 580 2008 116 121
96. M.A. Alvarez-Soria, G. Herrero-Beaumont, J. Moreno-Rubio, E. Calvo, J. Santillana, and J. Egido Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis Osteoarthritis Cartilage 16 2008 1484 1493
97. C. Zhao, N. Irie, Y. Takada, K. Shimoda, T. Miyamoto, and T. Nishiwaki Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis Cell Metab 4 2006 111 121 (Pubitemid 44138718)
98. J.P. Himanen, N. Saha, and D.B. Nikolov Cell-cell signaling via Eph receptors and ephrins Curr Opin Cell Biol 19 2007 534 542 (Pubitemid 350016850)
99. S. Kwan Tat, J.P. Pelletier, N. Amiable, C. Boileau, D. Lajeunesse, and N. Duval Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts Arthritis Rheum 58 2008 3820 3830